Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 15, 2009

GenWay Lab Obtains CLIA Certification

  • GenWay Biotech reports that it has become CLIA certified and received a California lab license. The company is seeking to obtain CAP (College of American Pathologists) accreditation by the end of the year. Furthermore, GenWay’s lab is under construction for the addition of a Class 10,000 clean room, which should be complete in August.

    GenWay, which has traditionally supplied antibodies and antigens for the development of diagnostic kits, will now be able to test immunological biomarkers for the develop diagnostic tests. The company says that in the coming weeks it will add cancer biomarker tests to its portfolio as well as tests for infectious diseases such as sexual transmitted diseases. 

    GenWay’s platform focuses on producing avian IgY antibodies from proteins of human, animal, plant, bacterial, and other sources. The company also offers single chain recombinant scFv and shark vNAR antibody technologies.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »